US SEC Form D Record

Swift Cardiovascular, Inc.

View External Record

SEC Filing Date

Sep 24, 2026

Capital / Financials

$1.5M Offered (SEC filing)

Funding stage not verified

Registered Location

DURHAM,

Legal Status

7 Backers

Industry Classification

Biotechnology

Corporate Dossier

Listed Founders / Executives

Jeffrey Lawson
Kemal Schankereli
Howard Kelly
Richard Murphy
Jospeh Long

Semantic Peers & Competitors ROOT: BIOTECHNOLOGY

These records share industry text with this entity. Text overlap is exploratory and does not establish that the entities are competitors or commercially comparable.

US SEC filing

Entera Bio Ltd. (ENTX)

$275M Offered (SEC filing)

US SEC filing

Georgiamune, Inc.

$131.9M Offered (SEC filing)